Julie A. Cullivan Sells 1,261 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Axon Enterprise Trading Up 0.3 %

Axon Enterprise stock traded up $2.39 during mid-day trading on Thursday, hitting $689.78. 732,380 shares of the company’s stock were exchanged, compared to its average volume of 566,444. Axon Enterprise, Inc. has a fifty-two week low of $231.83 and a fifty-two week high of $695.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $52.60 billion, a P/E ratio of 177.85, a PEG ratio of 14.74 and a beta of 1.01. The company’s 50 day simple moving average is $504.47 and its 200-day simple moving average is $387.43.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Craig Hallum boosted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Barclays lifted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research note on Tuesday. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $460.33.

Hedge Funds Weigh In On Axon Enterprise

Institutional investors have recently modified their holdings of the business. CIBC Asset Management Inc raised its holdings in Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after buying an additional 895 shares during the period. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at $221,000. Sequoia Financial Advisors LLC increased its holdings in Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares in the last quarter. Axxcess Wealth Management LLC bought a new position in Axon Enterprise during the 3rd quarter worth about $814,000. Finally, Soros Capital Management LLC bought a new stake in shares of Axon Enterprise in the third quarter valued at about $630,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.